These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31772533)

  • 21. Impact of Anatomical and Viability-Guided Completeness of Revascularization on Clinical Outcomes in Ischemic Cardiomyopathy.
    Ezad SM; McEntegart M; Dodd M; Didagelos M; Sidik N; Li Kam Wa M; Morgan HP; Pavlidis A; Weerackody R; Walsh SJ; Spratt JC; Strange J; Ludman P; Chiribiri A; Clayton T; Petrie MC; O'Kane P; Perera D;
    J Am Coll Cardiol; 2024 Jul; 84(4):340-350. PubMed ID: 38759904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Impella Recover 2.5 and TandemHeart ventricular assist devices are safe and associated with equivalent clinical outcomes in patients undergoing high-risk percutaneous coronary intervention.
    Kovacic JC; Nguyen HT; Karajgikar R; Sharma SK; Kini AS
    Catheter Cardiovasc Interv; 2013 Jul; 82(1):E28-37. PubMed ID: 21234916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender difference with the use of percutaneous left ventricular assist device in patients undergoing complex high-risk percutaneous coronary intervention: From pVAD Working Group.
    Doshi R; Singh A; Jauhar R; Meraj PM
    Eur Heart J Acute Cardiovasc Care; 2019 Jun; 8(4):369-378. PubMed ID: 29308660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Aug; 114(4):555-61. PubMed ID: 24996550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Procedural Volume and Outcomes After Percutaneous Coronary Intervention for Unprotected Left Main Coronary Artery Disease
    Aikawa T; Yamaji K; Nagai T; Kohsaka S; Kamiya K; Omote K; Inohara T; Numasawa Y; Tsujita K; Amano T; Ikari Y; Anzai T
    J Am Heart Assoc; 2020 May; 9(9):e015404. PubMed ID: 32347146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender disparities with the use of percutaneous left ventricular assist device in patients undergoing percutaneous coronary intervention complicated by cardiogenic shock: From pVAD Working Group.
    Doshi R; Patel K; Decter D; Jauhar R; Meraj P
    Indian Heart J; 2018 Jul; 70 Suppl 1(Suppl 1):S90-S95. PubMed ID: 30122245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility and efficacy of the 2.5 L and 3.8 L impella percutaneous left ventricular support device during high-risk, percutaneous coronary intervention in patients with severe aortic stenosis.
    Spiro J; Venugopal V; Raja Y; Ludman PF; Townend JN; Doshi SN
    Catheter Cardiovasc Interv; 2015 May; 85(6):981-9. PubMed ID: 24408882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roadmap towards an institutional Impella programme for high-risk coronary interventions.
    Pietrasik A; Gąsecka A; Jasińska-Gniadzik K; Szwed P; Grygier M; Pawłowski T; Sacha J; Kochman J
    ESC Heart Fail; 2023 Aug; 10(4):2200-2213. PubMed ID: 37345215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry.
    O'Neill WW; Schreiber T; Wohns DH; Rihal C; Naidu SS; Civitello AB; Dixon SR; Massaro JM; Maini B; Ohman EM
    J Interv Cardiol; 2014 Feb; 27(1):1-11. PubMed ID: 24329756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy.
    Russo JJ; Prasad M; Doshi D; Karmpaliotis D; Parikh MA; Ali ZA; Popma JJ; Pershad A; Ohman EM; Douglas PS; O'Neill WW; Leon MB; Moses JW; Kirtane AJ
    Catheter Cardiovasc Interv; 2020 Oct; 96(4):764-770. PubMed ID: 31693292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG).
    Pandey A; McGuire DK; de Lemos JA; Das SR; Berry JD; Brilakis ES; Banerjee S; Marso SP; Barsness GW; Simon DN; Roe M; Goyal A; Kosiborod M; Amsterdam EA; Kumbhani DJ
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):197-205. PubMed ID: 27166210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcomes in patients undergoing complex, high-risk percutaneous coronary intervention and haemodynamic support with intra-aortic balloon versus Impella pump: Real-life single-centre preliminary results.
    Januszek R; Pawlik A; Rzeszutko Ł; Bartuś K; Bartuś S
    Kardiol Pol; 2022; 80(12):1224-1231. PubMed ID: 36047958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized Clinical Trial of Surgical vs. Percutaneous vs. Hybrid Revascularization in Multivessel Coronary Artery Disease: Residual Myocardial Ischemia and Clinical Outcomes at One Year-Hybrid coronary REvascularization Versus Stenting or Surgery (HREVS).
    Ganyukov V; Kochergin N; Shilov A; Tarasov R; Skupien J; Szot W; Kokov A; Popov V; Kozyrin K; Barbarash O; Barbarash L; Musialek P
    J Interv Cardiol; 2020; 2020():5458064. PubMed ID: 31969796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multivessel disease in patients over 75years old with ST elevated myocardial infarction. Current management strategies and related clinical outcomes in the ESTROFA MI+75 nation-wide registry.
    de La Torre Hernandez JM; Gomez Hospital JA; Baz JA; Brugaletta S; Perez de Prado A; Linares JA; Lopez Palop R; Cid B; Garcia Camarero T; Diego A; Gutierrez H; Fernandez Diaz JA; Sanchis J; Alfonso F; Blanco R; Botas J; Navarro Cuartero J; Moreu J; Bosa F; Vegas JM; Elizaga J; Arrebola AL; Hernandez F; Salvatella N; Monteagudo M; Gomez Jaume A; Carrillo X; Martin Reyes R; Lozano F; Rumoroso JR; Andraka L; Dominguez AJ
    Cardiovasc Revasc Med; 2018; 19(5 Pt B):580-588. PubMed ID: 29306670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors and Prognostic Impact of Left Ventricular Ejection Fraction Recovery after Impella-Supported Percutaneous Coronary Interventions in Acute Myocardial Infarction.
    Marin F; Pighi M; Zucchelli F; Ruzzarin A; Russo G; Aurigemma C; Romagnoli E; Ferrero V; Piccoli A; Scarsini R; Pesarini G; Trani C; Burzotta F; Ribichini FL
    J Pers Med; 2022 Sep; 12(10):. PubMed ID: 36294715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of SYNTAX Score on 10-Year Outcomes After Revascularization for Left Main Coronary Artery Disease.
    Yoon YH; Ahn JM; Kang DY; Park H; Cho SC; Lee PH; Lee SW; Park SW; Park DW; Park SJ
    JACC Cardiovasc Interv; 2020 Feb; 13(3):361-371. PubMed ID: 32029254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study.
    Burzotta F; Paloscia L; Trani C; Mascellanti M; Mongiardo R; Materazzo G; Niccoli G; Di Marco M; Leone AM; Porto I; Mazzari MA; Rebuzzi AG; Schiavoni G; Crea F
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1004-10. PubMed ID: 18799962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
    J Am Coll Cardiol; 2015 Sep; 66(11):1209-1220. PubMed ID: 26361150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impella support and acute kidney injury during high-risk percutaneous coronary intervention: The Global cVAD Renal Protection Study.
    Flaherty MP; Moses JW; Westenfeld R; Palacios I; O'Neill WW; Schreiber TL; Lim MJ; Kaki A; Ghiu I; Mehran R
    Catheter Cardiovasc Interv; 2020 May; 95(6):1111-1121. PubMed ID: 31355987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.